[Transurethral electroresection with postoperative betatron irradiation in bladder cancer: indication and results].
100 patients suffering from infiltrating urinary bladder cancer underwent transurethral resection followed by external megavolt irradiation (Betatron) are presented. The value of irradiation and its role in the actual therapeutic concept is discussed. The results of the combined therapy in infiltrative urinary bladder cancer using transurethral resection and megavolt irradiation are demonstrated according to stage (T2, T3) and histological grading (G2, G3). The 5-years survival rate amounts around 80%, in deep infiltrating bladder cancer about 50%. The morbidity of postoperative megavolt therapy was negligible. The results are superior to megavolt therapy alone and approach the one achieved by radical surgery; in addition the possibility of salvage-cystectomy remains open.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011882:Radiotherapy, High-Energy; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy / Q000601:surgery*
Transurethrale Elektroresektion mit postoperativer Betatronbestrahlung bei Blasenkarzinom: Indikation und Ergebnisse.